ES2887625T3 - Soluciones orales que comprenden tramadol - Google Patents

Soluciones orales que comprenden tramadol Download PDF

Info

Publication number
ES2887625T3
ES2887625T3 ES18712544T ES18712544T ES2887625T3 ES 2887625 T3 ES2887625 T3 ES 2887625T3 ES 18712544 T ES18712544 T ES 18712544T ES 18712544 T ES18712544 T ES 18712544T ES 2887625 T3 ES2887625 T3 ES 2887625T3
Authority
ES
Spain
Prior art keywords
oral pharmaceutical
solution according
tramadol
pharmaceutical solution
polyols
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES18712544T
Other languages
English (en)
Spanish (es)
Inventor
Tsampikos Dimitrios Panagiotopoulos
Soultana Tziala
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboserve Pharmaceutical Co S A
Original Assignee
Laboserve Pharmaceutical Co S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboserve Pharmaceutical Co S A filed Critical Laboserve Pharmaceutical Co S A
Application granted granted Critical
Publication of ES2887625T3 publication Critical patent/ES2887625T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES18712544T 2018-02-20 2018-03-15 Soluciones orales que comprenden tramadol Active ES2887625T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GR20180100068A GR1009629B (el) 2018-02-20 2018-02-20 Ποσιμα διαλυματα που περιλαμβανουν τραμαδολη
PCT/EP2018/056566 WO2019161938A1 (en) 2018-02-20 2018-03-15 Oral solutions comprising tramadol

Publications (1)

Publication Number Publication Date
ES2887625T3 true ES2887625T3 (es) 2021-12-23

Family

ID=61750096

Family Applications (1)

Application Number Title Priority Date Filing Date
ES18712544T Active ES2887625T3 (es) 2018-02-20 2018-03-15 Soluciones orales que comprenden tramadol

Country Status (6)

Country Link
EP (1) EP3755373B1 (pt)
ES (1) ES2887625T3 (pt)
GR (1) GR1009629B (pt)
PL (1) PL3755373T3 (pt)
PT (1) PT3755373T (pt)
WO (1) WO2019161938A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11103452B2 (en) 2019-11-08 2021-08-31 Athena Bioscience, Llc Tramadol hydrochloride solution

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652589A (en) 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
DE19940740A1 (de) * 1999-08-31 2001-03-01 Gruenenthal Gmbh Pharmazeutische Salze
US7101572B2 (en) * 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
MXPA03012048A (es) * 2003-12-19 2005-06-23 Victor Guillermo Alvarez Ochoa Composiciones farmaceuticas en solucion inyectable que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
DE102006056458A1 (de) * 2006-11-28 2008-05-29 Grünenthal GmbH Arzneimittelzubereitung von Tramadol und Acetaminophen
MX2010011193A (es) * 2010-10-12 2012-04-18 World Trade Imp Exp Wtie Ag Composicion farmaceutica liquida para el tratamiento y prevencion del dolor.
ZA201300398B (en) * 2012-11-27 2013-09-25 Genfarma Laboratories S L Injectable liquid formulation of the combination of tramadol and paracetamol

Also Published As

Publication number Publication date
PT3755373T (pt) 2021-09-03
WO2019161938A1 (en) 2019-08-29
PL3755373T3 (pl) 2021-12-13
EP3755373A1 (en) 2020-12-30
GR1009629B (el) 2019-10-25
GR20180100068A (el) 2019-09-25
EP3755373B1 (en) 2021-07-28

Similar Documents

Publication Publication Date Title
ES2685178T3 (es) Soluciones pediátricas que contienen un beta bloqueante
ES2211192T3 (es) Jarabe antihistaminico estabilizado que contiene acido aminopolicarboxilico como estabilizante.
ES2929192T3 (es) Disoluciones orales que comprenden sales de lisdexanfetamina
EP3003384A1 (en) Oral solution comprising atomoxetine hydrochloride
CA2326356C (en) Oral liquid antidepressant solution
ES2887625T3 (es) Soluciones orales que comprenden tramadol
WO2019174755A1 (en) Oral solutions comprising tramadol and acetaminophen
ES2362581T3 (es) Composiciones que comprenden neramezano.
CN109640956B (zh) 具有改善的味道和感官体验的药物
NL2024160B1 (en) Pharmaceutical liquid composition, kit of parts comprising the pharmaceutical liquid composition, and method for preparing the pharmaceutical liquid composition
US20220387363A1 (en) Pharmaceutical liquid composition, kit of parts comprising the pharmaceutical liquid composition, and method for preparing the pharmaceutical liquid composition
GR1009513B (el) Ποσιμα φαρμακευτικα διαλυματα που περιλαμβανουν καρβοκυστεϊνη
Haywood et al. Solutions through compounding: Flavouring for children (Part 1)
JPH05194232A (ja) トリメトプリム経口液剤
WO2024211393A2 (en) Desmopressin oral compositions
CN115645357A (zh) 一种拉考沙胺口服溶液处方及其制备工艺
GR1009069B (el) Ποσιμα διαλυματα υψηλης συγκεντρωσης που περιεχουν υδροχλωρικη ρανιτιδινη
EP4108233A1 (en) Oral solution comprising a cinacalcet salt
US20120220630A1 (en) Prucalopride oral solution
GR20190100342A (el) Ποσιμα φαρμακευτικα διαλυματα που περιλαμβανουν χαμηλη συγκεντρωση υδροχλωρικης ρανιτιδινης καταλληλα για παιδιατρικη χρηση
MXPA00009677A (en) Oral liquid antidepressant solution